Tegoprazan and low- or high-dose amoxicillin dual therapy versus bismuth-containing quadruple therapy for eradication (TREAT): protocol for a multicenter, open-label, non-inferiority, randomized controlled trial

Tegoprazan and low- or high-dose amoxicillin dual therapy versus bismuth-containing quadruple therapy for eradication (TREAT): protocol for a multicenter, open-label, non-inferiority, randomized controlled trial

Background: Recently, tegoprazan was widely used for the treatment of acid-related diseases, including Helicobacter pylori ( H. pylori ) infection. However, the optimized parameters of tegoprazan and amoxicillin used in dual therapy for eradicating H. pylori remained unresolved. Objectives: We mainl...

Full description

Saved in:
Bibliographic Details
Main Authors: Yi Hu, Xin Xu, Cong He, Nian-Shuang Li, Yong Xie, Xu Shu, Nong-Hua Lu, Yin Zhu
Format: Article
Language:English
Published: SAGE Publishing 2025-08-01
Series:Therapeutic Advances in Gastroenterology
Online Access:https://doi.org/10.1177/17562848251366374
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items